Topotecan Compared With No Therapy After Response to Surgery and Carboplatin/Paclitaxel in Patients With Ovarian Cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) Randomized Study

MLA

Luigi Manzione, et al. “Topotecan Compared With No Therapy After Response to Surgery and Carboplatin/Paclitaxel in Patients With Ovarian Cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) Randomized Study.” Journal of Clinical Oncology, vol. 22, July 2004, pp. 2635–42. EBSCOhost, https://doi.org/10.1200/jco.2004.09.088.

APA

Luigi Manzione, Andrea de Matteis, Emanuele Naglieri, R. Biamonte, Giovanni Scambia, Gianpietro Gasparini, Marco Marinaccio, Stefano Greggi, Giacomo Cartenì, Rossella Lauria, Sabino De Placido, Antonio Febbraro, Alessandra Vernaglia Lombardi, S. Danese, Francesco Perrone, Maria Rosaria Valerio, Michele De Laurentiis, Giovanni Di Vagno, Sandro Pignata, & Ciro Gallo. (2004). Topotecan Compared With No Therapy After Response to Surgery and Carboplatin/Paclitaxel in Patients With Ovarian Cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) Randomized Study. Journal of Clinical Oncology, 22, 2635–2642. https://doi.org/10.1200/jco.2004.09.088

Chicago

Luigi Manzione, Andrea de Matteis, Emanuele Naglieri, R. Biamonte, Giovanni Scambia, Gianpietro Gasparini, Marco Marinaccio, et al. 2004. “Topotecan Compared With No Therapy After Response to Surgery and Carboplatin/Paclitaxel in Patients With Ovarian Cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) Randomized Study.” Journal of Clinical Oncology 22 (July): 2635–42. doi:10.1200/jco.2004.09.088.